0001140361-18-028331.txt : 20180613 0001140361-18-028331.hdr.sgml : 20180613 20180613130802 ACCESSION NUMBER: 0001140361-18-028331 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180613 DATE AS OF CHANGE: 20180613 EFFECTIVENESS DATE: 20180613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-314487 FILM NUMBER: 18896261 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 D 1 primary_doc.xml X0708 D LIVE 0000357097 Fibrocell Science, Inc. 405 EAGLEVIEW BOULEVARD EXTON PA PENNSYLVANIA 19341 484-713-6000 DELAWARE None ISOLAGEN INC AMERICAN FINANCIAL HOLDING INC /DE AMERICAN FINANCIAL HOLDING INC /CO Corporation true JOHN M. MASLOWSKI 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Executive Officer Director President and Chief Executive Officer JULIAN P. KIRK 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Director MARC B. MAZUR 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Director KELVIN D. MOORE 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Director MARCUS E. SMITH 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Director CHRISTINE ST.CLARE 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Director DOUGLAS J. SWIRSKY 405 EAGLEVIEW BLVD. EXTON PA PENNSYLVANIA 19341 Director Chairman of the Board Biotechnology Decline to Disclose 06b false 2018-05-29 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NJ NEW JERSEY NY NEW YORK true 5087980 5087980 0 The warrants and underlying shares of common stock include warrants (i) to purchase 1,528,668 shares of common stock issued to certain institutional investors and (ii) to purchase 142,676 shares of common stock issued to H.C. Wainwright ("HCW Warrants") false 4 13376 0 H.C. Wainwright received the above sales commissions in connection with the private placement of warrants. It also received the HCW Warrants in connection with a registered direct offering by the Company. 0 false Fibrocell Science, Inc. /s/ John M. Maslowski John M. Maslowski President and Chief Executive Officer 2018-06-13